This paper will propose a framework for evaluating translational research by identifying the way in which translational research occurs in practice (rather than the formal linear stages in which the results of such process are typically presented). Following previous work on methods to evaluation science-society interactions, our approach will focus on the processes of TR and the ways in which public initiatives to support new ways of conducting research succeed or fail.
In this study, we analyze the determinants of biomedical scientists’ participation in various types of activities and outputs related to medical innovation. More specifically, we argue that scientists occupying brokerage positions among their contacts will in a more favorable position to deliver medical innovation outcomes, compared to scientists embedded in more dense networks. However, we also theorize that beyond a threshold, the coordination costs of brokerage may surpass its potential benefits.